Skip to main content

Advertisement

SpringerLink
Log in

Higher Circulating Levels of Chemokine CCL20 in Patients with Multiple Sclerosis: Evaluation of the Influences of Chemokine Gene Polymorphism, Gender, Treatment and Disease Pattern

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Chemokines play an important role in the autoimmune diseases. The aim of this study was to investigate the levels of CCL20 and a polymorphism [-786C > T (rs6749704)] in the chemokine gene in patients with multiple sclerosis (MS). The blood samples were collected from 135 MS patients and 135 healthy subjects as a control group. The patients have relapsing-remitting (RRMS; n = 65), primary progressive (PPMS; n = 47), secondary progressive (SPMS; n = 35) or progressive relapsing (PRMS; n = 14) patterns. The serum levels of CCL20 were measured by ELISA. The DNA was analyzed for CCL20 polymorphism using PCR–RLFP. The mean serum levels of CCL20 in the MS group were significantly higher than in the healthy group (P < 0.001). In patients with a SPMS pattern, the frequency of CT genotype at rs6749704 (24.3 %) was significantly lower as compared to patients with other patterns (42.8 %; P < 0.04). No significant differences were observed between subjects with different genotypes in rs6749704 regarding the CCL20 levels. The mean serum levels of CCL20 in both newly diagnosed and previously diagnosed patients was significantly higher than in the healthy group (P < 0.05 and 0.001, respectively). The mean serum levels of CCL20 in patients with RRMS, SPMS and PPMS patterns were significantly higher than in the healthy group (P < 0.004, P < 0.04, and 0.05, respectively). The levels of CCL20 in untreated patients and in patients who received interferon-β, methylprednisolone or the combination of interferon-β plus methylprednisolone were higher as compared to the control group (P < 0.05, P < 0.03, P < 0.005, and P < 0.05, respectively). These results showed higher levels of CCL20 in patients that represent that the chemokine may play an important role in the pathogenesis of MS. The rs6749704 polymorphism was an associated SPMS pattern. The levels of CCL20 were not influenced by gender, disease pattern and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ambrosini E, Columba-Cabezas S, Serafini B, Muscella A, Aloisi F (2003) Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia 41:290–300

    Article  PubMed  Google Scholar 

  • Anlar O (2009) Treatment of multiple sclerosis. CNS Neurol Disord Drug Targets 8:167–174

    Article  CAS  PubMed  Google Scholar 

  • Buc M (2013) Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis. Mediators Inflamm 2013:963748

    Article  PubMed Central  PubMed  Google Scholar 

  • Christensen JR, Bornsen L, Ratzer R, Piehl F, Khademi M, Olsson T, Sorensen PS, Sellebjerg F (2013) Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression. PLoS One 8:e57820

    Article  CAS  PubMed Central  Google Scholar 

  • Hoglund RA, Holmoy T, Harbo HF, Maghazachi AA (2013) A one year follow-up study of natural killer and dendritic cells activities in multiple sclerosis patients receiving glatiramer acetate (GA). PLoS One 8:e62237

    Article  PubMed Central  PubMed  Google Scholar 

  • Holman DW, Klein RS, Ransohoff RM (2011) The blood–brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta 1812:220–230

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Jadidi-Niaragh F, Mirshafiey A (2011) Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 74:1–13

    Article  CAS  PubMed  Google Scholar 

  • Kalinowska-Lyszczarz A, Szczucinski A, Pawlak MA, Losy J (2011) Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients. J Neurol Sci 300:81–85

    Article  CAS  PubMed  Google Scholar 

  • Kallaur AP, Oliveira SR, Colado Simao AN, Delicato de Almeida ER, Kaminami Morimoto H, Lopes J, de Carvalho Jennings Pereira WL, Marques Andrade R, Muliterno Pelegrino L, Donizete Borelli S, Kaimen-Maciel DR, Reiche EM (2013) Cytokine profile in relapsingremitting multiple sclerosis patients and the association between progression and activity of the disease. Mol Med Rep 7:1010–1020

    CAS  PubMed  Google Scholar 

  • Kuchroo VK, Awasthi A (2012) Emerging new roles of Th17 cells. Eur J Immunol 42:2211–2214

    Article  CAS  PubMed  Google Scholar 

  • Lee AY, Eri R, Lyons AB, Grimm MC, Korner H (2013) CC Chemokine Ligand 20 and Its Cognate Receptor CCR6 in Mucosal T Cell Immunology and Inflammatory Bowel Disease: Odd Couple or Axis of Evil? Front Immunol 4:194

    Article  PubMed Central  PubMed  Google Scholar 

  • Maddur MS, Miossec P, Kaveri SV, Bayry J (2012) Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 181:8–18

    Article  CAS  PubMed  Google Scholar 

  • Matsushita T, Tateishi T, Isobe N, Yonekawa T, Yamasaki R, Matsuse D, Murai H, Kira J (2013) Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis. PLoS One 8:e61835

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127

    Article  CAS  PubMed  Google Scholar 

  • Meares GP, Ma X, Qin H, Benveniste EN (2012) Regulation of CCL20 expression in astrocytes by IL-6 and IL-17. Glia 60:771–781

    Article  PubMed  Google Scholar 

  • Raman D, Sobolik-Delmaire T, Richmond A (2011) Chemokines in health and disease. Exp Cell Res 317:575–589

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, Sallusto F (2009) C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10:514–523

    Article  CAS  PubMed  Google Scholar 

  • Rentzos M, Nikolaou C, Rombos A, Evangelopoulos ME, Kararizou E, Koutsis G, Zoga M, Dimitrakopoulos A, Tsoutsou A, Sfangos C (2008) Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse. Clin Neurol Neurosurg 110:992–996

    Article  PubMed  Google Scholar 

  • Rodgers JM, Miller SD (2012) Cytokine control of inflammation and repair in the pathology of multiple sclerosis. Yale J Biol Med 85:447–468

    CAS  PubMed Central  PubMed  Google Scholar 

  • Rostami A, Ciric B (2013) Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. J Neurol Sci 333(1-2):76–87. doi:10.1016/j.jns.2013.03.002

    Article  CAS  PubMed  Google Scholar 

  • Szczucinski A, Kalinowska A, Losy J (2007) CXCL11 (Interferon-inducible T-cell alpha chemoattractant) and interleukin-18 in relapsing-remitting multiple sclerosis patients treated with methylprednisolone. Eur Neurol 58:228–232

    Article  CAS  PubMed  Google Scholar 

  • Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008) Th17 cells in human disease. Immunol Rev 223:87–113

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Wang X, Ma C, Wu J, Zhu J (2013) Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barre syndrome as well as their animal models. J Neurosci Res 91:871–881

    Article  CAS  PubMed  Google Scholar 

  • Zhang W, Nie L, Wang Y, Wang XP, Zhao H, Dongol S, Maharjan S, Cheng L (2013) CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues. PLoS One 8:e66286

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zhou Y, Sonobe Y, Akahori T, Jin S, Kawanokuchi J, Noda M, Iwakura Y, Mizuno T, Suzumura A (2011) IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. J Immunol 186:4415–4421

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology Research Center, Department of Neurology, Kerman University of Medical Sciences, Kerman, Iran

    A. Jafarzadeh, H. A. Ebrahimi, F. Gadari, A. Sabahi & F. Iranmanesh

  2. Department of Immunology, Medical School, Kerman University of Medical Sciences, Kerman, Iran

    A. Jafarzadeh, S. Bagherzadeh, H. Hajghani, A. Khosravimashizi, M. Nemati, M. M. Mohammadi & H. Daneshvar

  3. Department of Immunology, Medical School, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

    A. Jafarzadeh

  4. Department of Medical Genetic, Medical School, Kerman University of Medical Sciences, Kerman, Iran

    M. R. Bazrafshani

Authors
  1. A. Jafarzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Bagherzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. A. Ebrahimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Hajghani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. R. Bazrafshani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Khosravimashizi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Nemati
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F. Gadari
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A. Sabahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. F. Iranmanesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M. M. Mohammadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. H. Daneshvar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Jafarzadeh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jafarzadeh, A., Bagherzadeh, S., Ebrahimi, H.A. et al. Higher Circulating Levels of Chemokine CCL20 in Patients with Multiple Sclerosis: Evaluation of the Influences of Chemokine Gene Polymorphism, Gender, Treatment and Disease Pattern. J Mol Neurosci 53, 500–505 (2014). https://doi.org/10.1007/s12031-013-0214-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-013-0214-2

Keywords

Search

Navigation